Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection

Cellular Microbiology

Volumn 16, Issue 9, 2014, Pages 1285-1300

  Lewis, Michael D ^a   Fortes Francisco, Amanda ^a   Taylor, Martin C ^a   Burrell Saward, Hollie ^a   Mclatchie, Alex P ^a,b   Miles, Michael A ^a   Kelly, John M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; GASTROINTESTINAL TRACT; HEART DISEASE; HEART MUSCLE FIBROSIS; LIMIT OF DETECTION; MOUSE; MYOCARDITIS; NONHUMAN; PARASITE IDENTIFICATION; PARASITE LOAD; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMIASIS; ANIMAL; BAGG ALBINO MOUSE; CHAGAS DISEASE; FEMALE; LUMINESCENCE; METABOLISM; PARASITOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; FEMALE; HEART DISEASES; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI;

EID: 84904610210     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12297     Document Type: Article

References (63)

1. Adad, S.J., Andrade, D.C.D.S., Lopes, E.R., and Chapadeiro, E. (1991) Contribuição ao estudo da anatomia patológica do megaesôfago chagásico. Rev Inst Med Trop Sao Paulo 33: 443-450.
2. Anderson, C.F., Oukka, M., Kuchroo, V.J., and Sacks, D. (2007) CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204: 285-297.
3. Andrade, S.G., and Magalhães, J.B. (1997) Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Rev Soc Bras Med Trop 30: 27-35.
4. Andriani, G., Chessler, A.-D.C., Courtemanche, G., Burleigh, B.A., and Rodriguez, A. (2011) Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening. PLoS Negl Trop Dis 5: e1298.
5. Añez, N., Carrasco, H., Parada, H., Crisante, G., Rojas, A., Fuenmayor, C., etal. (1999) Myocardial parasite persistence in chronic chagasic patients. Am J Trop Med Hyg 60: 726-732.
6. Arantes, R.M.E., Marche, H.H.F., Bahia, M.T., Cunha, F.Q., Rossi, M.A., and Silva, J.S. (2004) Interferon-γ-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. Am J Pathol 164: 1361-1368.
7. Basile, L., Jansà, J.M., Carlier, Y., Salamanca, D.D., Angheben, A., Bartoloni, A., etal. (2011) Chagas disease in European countries: the challenge of a surveillance system. Eurosurveillance 16: 19968.
8. Belkaid, Y., Hoffmann, K.F., Mendez, S., Kamhawi, S., Udey, M.C., Wynn, T.A., and Sacks, D.L. (2001) The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194: 1497-1506.
9. Belkaid, Y., Piccirillo, C.A., Mendez, S., Shevach, E.M., and Sacks, D.L. (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
10. Bern, C. (2011) Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med 364: 2527-2534.
11. Bern, C., and Montgomery, S.P. (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49: e52-e54.
12. Bonney, K.M., and Engman, D.M. (2008) Chagas heart disease pathogenesis: one mechanism or many? Curr Mol Med 8: 510-518.
13. Bot, C., Hall, B.S., Bashir, N., Taylor, M.C., Helsby, N.A., and Wilkinson, S.R. (2010) Trypanocidal activity of aziridinyl nitrobenzamide prodrugs. Antimicrob Agents Chemother 54: 4246-4252.
14. Branchini, B.R., Ablamsky, D.M., Davis, A.L., Southworth, T.L., Butler, B., Fan, F., etal. (2010) Red-emitting luciferases for bioluminescence reporter and imaging applications. Anal Biochem 396: 290-297.
15. Calderón, J., Maganto-Garcia, E., Punzón, C., Carrión, J., Terhorst, C., and Fresno, M. (2012) The receptor Slamf1 on the surface of myeloid lineage cells controls susceptibility to infection by Trypanosoma cruzi. PLoS Pathog 8: e1002799.
16. Caliari, M.V. (1997) Princípios de Morfometria Digital: KS300 para iniciantes Belo Horizonte, Brazil, Editora UFMG.
17. Caliari, M.V., Machado, R.D.P., de Lana, M., Cajá, R.A.F., Carneiro, C.M., Bahia, M.T., etal. (2002) Quantitative analysis of cardiac lesions in chronic canine chagasic cardiomyopathy. Rev Inst Med Trop Sao Paulo 44: 273-278.
18. Canavaci, A.M.C., Bustamante, J.M., Padilla, A.M., Perez Brandan, C.M., Simpson, L.J., Xu, D., etal. (2010) In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. PLoS Negl Trop Dis 4: e740.
19. de Castro Côbo, E., Silveira, T.P., Micheletti, A.M., Crema, E., and Adad, S.J. (2012) Research on Trypanosoma cruzi and analysis of inflammatory infiltrate in Esophagus and Colon from chronic Chagasic patients with and without mega. J Trop Med 2012: 232646.
20. Cencig, S., Coltel, N., Truyens, C., and Carlier, Y. (2011) Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome. PLoS Negl Trop Dis 5: e1216.
21. Cummings, K.L., and Tarleton, R.L. (2003) Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol Biochem Parasitol 129: 53-59.
22. Cunha-Neto, E., Teixeira, P.C., Nogueira, L.G., and Kalil, J. (2011) Autoimmunity. In Advances in Parasitology. Louis, M.W., and Herbert, B.T. (eds). San Diego, CA: Academic Press, pp. 129-152.
23. Dutra, W.O., and Gollob, K.J. (2008) Current concepts in immunoregulation and pathology of human Chagas disease. Curr Opin Infect Dis 21: 287-292.
24. Ferreira, M.S., Nishioka, S.D.A., Silvestre, M.T.A., Borges, A.S., Araújo, F.R.F.N., and Rocha, A. (1997) Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis 25: 1397-1400.
25. Gironès, N., and Fresno, M. (2003) Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol 19: 19-22.
26. Gutierrez, F.R.S., Guedes, P.M.M., Gazzinelli, R.T., and Silva, J.S. (2009) The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol 31: 673-685.
27. Higuchi, M.D.L., Gutierrez, P.S., Aiello, V.D., Palomino, S., Bocchi, E., Kalil, J., etal. (1993) Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch 423: 157-160.
28. Hyland, K.V., Asfaw, S.H., Olson, C.L., Daniels, M.D., and Engman, D.M. (2008) Bioluminescent imaging of Trypanosoma cruzi infection. Int J Parasitol 38: 1391-1400.
29. Isola, E.L., Lammel, E.M., and Gonzalez Cappa, S.M. (1986) Trypanosoma cruzi: differentiation after interaction of epimastigotes and Triatoma infestans intestinal homogenate. Exp Parasitol 62: 329-335.
30. Jones, E.M., Colley, D.G., Tostes, S., Lopes, E.R., Vnencak-Jones, C.L., and McCurley, T.L. (1993) Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48: 348-357.
31. Kendall, G., Wilderspin, A.F., Ashall, F., Miles, M.A., and Kelly, J.M. (1990) Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the 'hotspot' topogenic signal model. EMBO J 9: 2751-2758.
32. Köberle, F. (1970) The causation and importance of nervous lesions in American trypanosomiasis. Bull World Health Organ 42: 739-743.
33. La Flamme, A.C., Kahn, S.J., Rudensky, A.Y., and Van Voorhis, W.C. (1997) Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation. Eur J Immunol 27: 3085-3094.
34. Lenzi, H.L., Oliveira, D.N., Lima, M.T., and Gattass, C.R. (1996) Trypanosoma cruzi: paninfectivity of CL strain during murine acute infection. Exp Parasitol 84: 16-27.
35. Lewis, M.D., Llewellyn, M.S., Yeo, M., Acosta, N., Gaunt, M.W., and Miles, M.A. (2011) Recent, independent and anthropogenic origins of Trypanosoma cruzi hybrids. PLoS Negl Trop Dis 5: e1363.
36. McLatchie, A.P., Burrell-Saward, H., Myburgh, E., Lewis, M.D., Ward, T.H., Mottram, J.C., etal. (2013) Highly sensitive in vivo imaging of Trypanosoma brucei expressing 'red-shifted' luciferase. PLoS Negl Trop Dis 7: e2571.
37. Macpherson, A.J., and Smith, K. (2006) Mesenteric lymph nodes at the center of immune anatomy. J Exp Med 203: 497-500.
38. Marin-Neto, J.A., Cunha-Neto, E., Maciel, B.C., and Simoes, M.V. (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-1123.
39. Marin-Neto, J.A., Rassi, A., Jr, Morillo, C.A., Avezum, A., Connolly, S.J., Sosa-Estani, S., etal. (2008) Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156: 37-43.
40. Marinho, C.R.F., Bucci, D.Z., Dagli, M.L.Z., Bastos, K.R.B., Grisotto, M.G., Sardinha, L.R., etal. (2004) Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease. Infect Immun 72: 2350-2357.
41. Matos Ferreira, A.V., Segatto, M., Menezes, Z., Macedo, A.M., Gelape, C., de Oliveira Andrade, L., etal. (2011) Evidence for Trypanosoma cruzi in adipose tissue in human chronic Chagas disease. Microbes Infect 13: 1002-1005.
42. Melo, R., and Brener, Z. (1978) Tissue tropism of different Trypanosoma cruzi strains. J Parasitol 64: 475-482.
43. Moncayo, Á., and Silveira, A.C. (2009) Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 104: 17-30.
44. Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C.L., Cheroutre, H., and Kronenberg, M. (2009) Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10: 1178-1184.
45. Nagajyothi, F., Machado, F.S., Burleigh, B.A., Jelicks, L.A., Scherer, P.E., Mukherjee, S., etal. (2012) Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cell Microbiol 14: 634-643.
46. de Oliveira, R.B., Troncon, L.E., Dantas, R.O., and Menghelli, U.G. (1998) Gastrointestinal manifestations of Chagas' disease. Am J Gastroenterol 93: 884-889.
47. Padilla, A.M., Bustamante, J.M., and Tarleton, R.L. (2009) CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol 21: 385-390.
48. Palomino, S.A.P., Aiello, V.D., and Higuchi, M.L. (2000) Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 94: 571-579.
49. Piacenza, L., Alvarez, M.N., Peluffo, G., and Radi, R. (2009) Fighting the oxidative assault: the Trypanosoma cruzi journey to infection. Curr Opin Microbiol 12: 415-421.
50. Piron, M., Fisa, R., Casamitjana, N., López-Chejade, P., Puig, L., Vergés, M., etal. (2007) Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 103: 195-200.
51. Postan, M., Bailey, J.J., Dvorak, J.A., McDaniel, J.P., and Pottala, E.W. (1987) Studies of Trypanosoma cruzi clones in inbred mice: III. Histopathological and electrocardiographical responses to chronic infection. Am J Trop Med Hyg 37: 541-549.
52. Rassi, A., de Rezende, J.M., Luquetti, A.O., and Rassi, A., Jr (2010) Clinical phases and forms of Chagas disease. In American Trypanosomiasis Chagas Disease. Telleria, J., and Tibayrenc, M. (eds). London, UK: Elsevier, pp. 732-741.
53. Riganti, J., Maqueda, M.G., Piñero, M.C.B., Volonteri, V., I, and Galimberti, R.L. (2012) Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients. Int J Dermatol 51: 829-834.
54. Rodrigues, C.M., Valadares, H.M.S., Francisco, A.F., Arantes, J.M., Campos, C.F., Teixeira-Carvalho, A., etal. (2010) Coinfection with different Trypanosoma cruzi strains interferes with the host immune response to infection. PLoS Negl Trop Dis 4: e846.
55. Roffê, E., Souza, A.L.S., Caetano, B.C., Machado, P.P., Barcelos, L.S., Russo, R.C., etal. (2006) A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats. Microbes Infect 8: 2745-2755.
56. Roffê, E., Rothfuchs, A.G., Santiago, H.C., Marino, A.P.M.P., Ribeiro-Gomes, F.L., Eckhaus, M., etal. (2012) IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection. J Immunol 188: 649-660.
57. da Silveira, A.B.M., Arantes, R.M.E., Vago, A.R., Lemos, E.M., Adad, S.J., Correa-Oliveira, R., and D'Avila Reis, D. (2005) Comparative study of the presence of Trypanosoma cruzi kDNA, inflammation and denervation in chagasic patients with and without megaesophagus. Parasitology 131: 627-634.
58. Silverio, J.C., Pereira, I.R., Cipitelli, M.D.C., Vinagre, N.F., Rodrigues, M.M., Gazzinelli, R.T., and Lannes-Vieira, J. (2012) CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy. PLoS Pathog 8: e1002645.
59. Smythies, L.E., Sellers, M., Clements, R.H., Mosteller-Barnum, M., Meng, G., Benjamin, W.H., etal. (2005) Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66-75.
60. Tarleton, R.L. (2003) Chagas disease: a role for autoimmunity? Trends Parasitol 19: 447-451.
61. Teixeira, A.R.L., Hecht, M.M., Guimaro, M.C., Sousa, A.O., and Nitz, N. (2011) Pathogenesis of Chagas' disease: parasite persistence and autoimmunity. Clin Microbiol Rev 24: 592-630.
62. Waghabi, M.C., Coutinho, C.M.L.M., Soeiro, M.N.C., Pereira, M.C.S., Feige, J.-J., Keramidas, M., etal. (2002) Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor β levels in mice deficient in α2-macroglobulin. Infect Immun 70: 5115-5123.
63. Zhang, L., and Tarleton, R.L. (1999) Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infect Dis 180: 480-486.